A latest device for Heart bypass surgery was developed by a team of international Scientists that helps doctors to do the surgery on a heart that is beating.
Scientists from Moscow and their colleagues from Australia’s medical have developed a special device to enhance heart surgery with a stapler-like tool that restores the blood vessels using strong staples.
The stapler uses special flexible nickel titanium (nitinol). It is a reversible shape memory staples. The property of this metal is restoration of shape i.e., original shape can be restored after abnormal deformations. Innovations and Technology are significantly astonishing, the surgery that made people to believe is the first uterus transplant surgery – First Ever Uterus Transplant in U.S.
The staples are placed inside a cartridge and then inserted inside the polymer- body stapler’s distal end. In this technique Surgeons can simply drill two holes through it and place the bypass in place instead of separating the breast bone.
Researchers said, this new stitching instrument allows doctors to quickly and safely restore blood vessels and also it shortens the recovery period. While a normal heart bypass surgery takes up to five hours with doctors having to stop the heart but this latest surgery takes about an hour, and the patient can be discharged the following day.
ErlySign Oral Cancer Detection Technology Gets CDSCO Nod
ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]
Read MoreAdditional Steps Announced by FDA to Modernize Clinical Trials
The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]
Read MoreAccreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA
This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]
Read MoreBSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing
BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]
Read More
TUV SUD Inspects IVD Medical Devices’ Cyber Security
The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]
Read More
TGA Supports MHRA’s New Regulations
The TGA made a commitment to support the MHRA‘s new Regulations worldwide recognition framework for pharmaceuticals. Following the UK’s exit from the European Union, a new international recognition framework for medicines has been developed specifically […]
Read MoreMedical Devices with Extended CE Certification Are Now Accepted On The UK Market
The MHRA revised its guidelines to make clear its stance and reflect its intention to extend the acceptance of CE-marked medical devices on the British market beyond June 30th, 2023. A statutory document that will […]
Read More
The NMPA Enhanced Regulation of Cosmetic Medicine
According to a representative of the State Administration for Market Regulation, after the industry’s quick development, prominent issues like unethical medical practices, fake goods, false advertising, and price fraud emerged, endangering the health and interests […]
Read More
